According to Biomerica's latest financial reports the company has $5.31 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-05-31 | $9.71 M | 64.26% |
2022-05-31 | $5.91 M | 40.9% |
2021-05-31 | $4.19 M | -51.4% |
2020-05-31 | $8.64 M | 1158.19% |
2019-05-31 | $0.68 M | -43% |
2018-05-31 | $1.2 M | -1.68% |
2017-05-31 | $1.22 M | -35.12% |
2016-05-31 | $1.88 M | 73.57% |
2015-05-31 | $1.08 M | -27.88% |
2014-05-31 | $1.5 M | -38.9% |
2013-05-31 | $2.46 M | 129.25% |
2012-05-31 | $1.07 M | 8.9% |
2011-05-31 | $0.98 M | -6.25% |
2010-05-31 | $1.05 M | -37.78% |
2009-05-31 | $1.69 M | -16.16% |
2008-05-31 | $2.02 M | 290.92% |
2007-05-31 | $0.51 M | 320.02% |
2006-05-31 | $0.12 M | -65.79% |
2005-05-31 | $0.36 M | -4.87% |
2004-05-31 | $0.37 M | -29.68% |
2003-05-31 | $0.53 M | 62.23% |
2002-05-31 | $0.33 M | 86.55% |
2001-05-31 | $0.17 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | $0.97 B | 18,188.06% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | $0.29 B | 5,370.95% | ๐บ๐ธ USA |
Biolase
BIOL | $6.56 M | 23.44% | ๐บ๐ธ USA |